Literature DB >> 22993367

Colon neoplastic cells do not originate from bone marrow-derived cells after sex-mismatched bone marrow transplantation.

Gen Sakai1, Tomoharu Yajima, Hiromasa Takaishi, Takehiko Mori, Hajime Higuchi, Shoko Nakamura, Shinsuke Funakoshi, Masayuki Adachi, Motoko Izumiya, Hideko Akagi, Yasuo Hamamoto, Takanori Kanai, Makio Mukai, Shinichiro Okamoto, Toshifumi Hibi.   

Abstract

BACKGROUND: Although previous studies indicate that gastrointestinal (GI) cancer may originate from cells recruited from bone marrow (BM) in mice, whether similar phenomena occur in humans is controversial. In the current study, we evaluated two female patients who developed colonic adenocarcinoma more than 10 years after gender-mismatched BM transplantation, and followingly underwent successful endoscopic mucosal resection.
MATERIALS AND METHODS: Fluorescent in situ hybridization (FISH) analysis was used to determine whether the tumours contained donor-derived BM cells.
RESULTS: Approximately 1.2% of the tumour cells contained Y-chromosome-positive signals, and a comparable percentage of normal colonic epithelial cells close to the tumour also contained Y-chromosome-positive signals.
CONCLUSION: These results do not support the concept that GI cancer can originate from BM-derived cells.

Entities:  

Mesh:

Year:  2012        PMID: 22993367

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  2 in total

1.  Characterization of localized macrophages in bronchiolitis obliterans after allogeneic hematopoietic cell transplantation.

Authors:  Taiga Kuroi; Nobuharu Fujii; Koichi Ichimura; Keisuke Seike; Akira Yamamoto; Yui Kambara; Seiichiro Sugimoto; Shinji Otani; Kyosuke Saeki; Hideaki Fujiwara; Hisakazu Nishiomori; Takahiro Oto; Yoshinobu Maeda
Journal:  Int J Hematol       Date:  2021-09-07       Impact factor: 2.490

2.  Bone marrow-derived cells may not be the original cells for carcinogen-induced mouse gastrointestinal carcinomas.

Authors:  Chen Yang; Liankun Gu; Dajun Deng
Journal:  PLoS One       Date:  2013-11-19       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.